No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
AU Stock MarketDetailed Quotes
ATH Alterity Therapeutics Ltd
- 0.011
- +0.001+10.00%
20min DelayNot Open Feb 14 16:00 AET
57.70MMarket Cap-2.20P/E (Static)
0.011High0.010Low8.10MVolume0.011Open0.010Pre Close88.41KTurnover0.01952wk High0.17%Turnover Ratio5.25BShares0.00252wk Low--EPS TTM52.00MFloat Cap0.033Historical HighLossP/E (Static)4.73BShs Float0.002Historical Low-0.005EPS LYR10.00%Amplitude--Dividend TTM3.67P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Alterity Therapeutics Raises About AU$2.1 Million Via US Facility; Shares Soar 17%
Alterity Therapeutics (ASX:ATH) Shareholder Returns Have Been Stellar, Earning 260% in 1 Year
ADRs Advance; Alterity Therapeutics Ltd. Climbs 57%
Alterity Reports Positive Phase Two Trial Results for Multiple System Atrophy Drug Candidate, Shares Surge 125% to Record High
Alterity Therapeutics Ltd: ATH shareholder newsletter January 2025
Alterity Therapeutics Initiated at Buy by Maxim Group